Sanofi (SNYNF) Prepaid Assets (2009 - 2025)
Sanofi's (SNYNF) quarterly Prepaid Assets came in at $4.1 billion in Q2 2025, down 2.36% year-on-year from $4.2 billion in Q2 2024, and little changed quarter-over-quarter from $4.1 billion in Q4 2024.
Sanofi (SNYNF) Prepaid Assets (2009 - 2025) Analysis & Trends
Sanofi has disclosed Prepaid Assets across 17 years of filings, most recently posting $4.1 billion for Q2 2025.
- Prepaid Assets for Q2 2025 came in at $4.1 billion, down 2.36% year-over-year; the trailing twelve-month figure through Jun 2025 was $4.1 billion (down 2.36% YoY), and the FY2024 annual result was $4.1 billion, up 9.39% from the prior year.
- Prepaid Assets came in at $4.1 billion for Q2 2025 at Sanofi, roughly flat from $4.1 billion in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.2 billion in Q2 2024 to a low of $3.6 billion in Q4 2022.
- The 5-year median for Prepaid Assets is $3.9 billion (2022), against an average of $3.9 billion.
- Across the five-year window, Prepaid Assets jumped 6578.91% in 2021 and fell 11.79% in 2022, its largest moves.
- Sanofi's Prepaid Assets stood at $4.1 billion in 2021, then fell by 11.79% to $3.6 billion in 2022, then grew by 3.16% to $3.7 billion in 2023, then grew by 9.98% to $4.1 billion in 2024, then decreased by 0.47% to $4.1 billion in 2025.
- The last three Prepaid Assets figures came in at $4.1 billion (Q2 2025), $4.1 billion (Q4 2024), and $4.2 billion (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn |
| 10 | Sanofi | - | - | 9.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.07 Bn |
| Dec 31, 2024 | 4.09 Bn |
| Jun 30, 2024 | 4.17 Bn |
| Dec 31, 2023 | 3.72 Bn |
| Jun 30, 2023 | 3.67 Bn |
| Dec 31, 2022 | 3.60 Bn |
| Jun 30, 2022 | 3.94 Bn |
| Dec 31, 2021 | 4.09 Bn |
| Jun 30, 2021 | 3.73 Bn |
| Dec 31, 2020 | 61.16 Mn |
| Jun 30, 2020 | 3.00 Bn |
| Dec 31, 2019 | 44.16 Mn |
| Jun 30, 2019 | 3.28 Bn |
| Dec 31, 2018 | 3.33 Bn |
| Jun 30, 2018 | 42.96 Mn |
| Mar 31, 2018 | 2.71 Bn |
| Dec 31, 2017 | 395.62 Mn |
| Jun 30, 2017 | 2.30 Bn |
| Dec 31, 2016 | 359.55 Mn |
| Jun 30, 2016 | 76.83 Mn |